Rhodiola for Menopause: What the Evidence Shows

Updated August 2026

Rhodiola rosea grows where almost nothing else can. It roots into arctic cliffs and high-altitude rock across Europe, Asia, and North America, surviving cold, wind, and thin soil that would end most plants.

To survive there, the root builds an unusual set of protective compounds. Those compounds are the entire reason humans harvest it. For centuries, people in Russia and Scandinavia dug it up for endurance, fatigue, and long winters.

Whether that translates to a midlife nervous system is the actual question. The stress a plant survives on a cliff is not the stress you carry through perimenopause. So it is worth looking at what the research shows, and where it stops.

Key takeaways

• Rhodiola's strongest human evidence is for stress-related fatigue and burnout: real but modest effects on exhaustion, focus, and the morning cortisol response.
• The menopause-specific case rests on a 2016 hypothesis paper proposing estrogen-receptor activity. It is preclinical and unproven in women.
• Rhodiola is activating, so it belongs in the morning. It is generally well tolerated short term.
• Quality varies widely. Adulteration is documented in this herb, so third-party tested, standardized extracts matter more than usual.

What rhodiola is

Rhodiola rosea, also called arctic root or golden root, has a long record of traditional use in Russia and Scandinavia for work performance, endurance, fatigue, and altitude sickness. Source: NCCIH rhodiola overview

Modern herbalists class it as an adaptogen, meaning a botanical thought to support the body's response to stress. Its signature compounds are rosavins and salidroside. Rosavins are the fingerprint of true Rhodiola rosea, since related species do not make them the same way. Salidroside has shown protective effects on nerve cells in laboratory studies. Source: MSKCC rhodiola monograph

Quality extracts are standardized to both markers, commonly around 3% rosavins and 1% salidroside. That matters later, because plenty of products do not contain what the label says.

What the research shows, tier by tier

The evidence is uneven, so the fairest way to read it is in tiers. The strongest data covers stress-related fatigue. The menopause-specific data barely exists yet.

The best evidence: stress-related fatigue and burnout. In a randomized, placebo-controlled trial, 60 adults with stress-related fatigue took 576 mg per day of a standardized rhodiola extract for 28 days. Compared with placebo, they improved on a burnout scale, scored better on attention tests, and showed a reduced cortisol response to waking. Source: Olsson et al., 2009 RCT (PMID 19016404)

A 2017 multicenter study followed 118 adults with burnout symptoms taking 400 mg of rhodiola extract daily for 12 weeks. Emotional exhaustion, perceived stress, and mood improved, with some changes appearing within the first week. The catch: there was no placebo group, so the authors themselves called the results preliminary. Source: Kasper and Dienel, 2017 (PMC5370380)

The weaker tier: mood and cognition. Smaller studies suggest benefits for mental fatigue and mental performance. But the National Center for Complementary and Integrative Health is blunt about the field: most human research on rhodiola is of low to moderate quality, and there is not enough reliable evidence to confirm any specific health benefit. Source: NCCIH rhodiola overview

The fair summary: real signal for stress-related exhaustion, modest in size, from a literature that still needs bigger and better trials.

The menopause hypothesis, and why it is still just a hypothesis

No clinical trials have tested rhodiola for peri/menopause symptoms. What exists is an idea.

In 2016, two researchers published a paper in Phytomedicine proposing that Rhodiola rosea be investigated as a natural selective estrogen receptor modulator, or SERM: a compound that interacts with estrogen receptors differently in different tissues. They argued rhodiola compounds may bind estrogen receptors and influence related cell signaling, which could make it relevant to menopausal fatigue, cognition, bone, and heart health. Source: Gerbarg and Brown, 2016 hypothesis paper (PMID 26776957)

Read that carefully. The evidence behind it is preclinical: laboratory and mechanistic work, plus a call for future research. Proposing a mechanism is how science starts, not how it concludes. Until controlled trials test rhodiola in peri/menopausal women, the estrogen-receptor story stays unproven.

Where rhodiola fits in perimenopause

Rhodiola's realistic lane in perimenopause is the fatigue side: the flat-battery mornings, the stress-related exhaustion, the focus that fades by early afternoon.

That lane matters. In our 30-day consumer research study of 35 women in peri/menopause, energy and fatigue scored a mean of 3.08 out of 5 in severity, with 44% at high severity. Brain fog ranked even higher at 3.27. Source: Project M study results

If your dominant experience is depleted energy under sustained stress, rhodiola is one of the few single herbs with placebo-controlled data pointing that direction. It pairs naturally with the bigger energy picture in why perimenopause drains your energy and with how cortisol behaves in perimenopause. For how it compares to other adaptogens, see our guide to adaptogens for perimenopause.

How to use rhodiola well

Take it in the morning, choose a standardized extract, and verify third-party testing. Those three rules cover most of what goes wrong.

• Morning dosing. Rhodiola is activating, not sedating. Taken late, it can disturb sleep. Insomnia is among its reported side effects. Source: NCCIH rhodiola overview
• Standardized extracts. The trials above used defined extracts at set doses, commonly 400 to 600 mg daily. An unstandardized powder is not what was studied.
• Third-party testing. Adulteration is documented in this herb. When researchers analyzed roughly 40 commercial rhodiola products, about one in five contained no rosavins at all. A cheaper species, Rhodiola crenulata, was a common substitute. Source: Booker et al., 2016 (PMID 26626192)
• Know the cautions. Rhodiola is generally well tolerated short term. Dizziness, dry mouth, and headache are the most common complaints. Use caution with antidepressants, stimulants, or blood pressure medication, since interactions have been reported. Activating botanicals are generally not advised for people with bipolar disorder without medical supervision. Talk with your doctor first. Source: MSKCC rhodiola monograph

What rhodiola does not cover

Rhodiola is a single herb working mainly on one axis: stress-related energy and stamina. Perimenopause is not a single-axis experience.

It has no clinical evidence for cycle changes. It does not address internal heat or night sweats. It is not built for the tense, can't-unwind feeling, the 1 to 3 a.m. wakings, or the irritability our study participants ranked among their heaviest loads. A strong tool for one lane is still one lane.

Where The Shift fits

The Shift is Project M's daily herbal protocol for perimenopause and menopause, built on a formula that has been the standard of care in Asia for 600+ years. You can see the full formula here.

The design difference is architecture. Rhodiola is a single-pathway adaptogen. The Shift is a multi-herb formula built for the multi-system load of the transition: Bupleurum (Chai Hu) to support the stress response, Peony (Bai Shao) to soften tension, Gardenia (Zhi Zi) to vent internal heat, with Ginger and Licorice supporting absorption. In our 30-day consumer research study, participants tracked changes across brain fog, tension, mood, sleep, and energy together, because that is how the transition shows up. Source: Project M study results

Some women use both, taking rhodiola in the morning for energy alongside The Shift's broader support, with their doctor informed. Traditional Chinese Medicine (TCM) has long worked this way, matching the formula to the whole pattern rather than chasing one symptom with one herb.

One herb answers one signal. The transition asks for a system.

Frequently asked questions

Does rhodiola help with menopause symptoms?

There are no clinical trials of rhodiola for peri/menopause symptoms specifically. Its best evidence is for stress-related fatigue and burnout, which overlap with the low-energy side of perimenopause. The 2016 paper proposing menopause-specific estrogen-receptor activity is a hypothesis backed by preclinical data only. Source: Gerbarg and Brown, 2016 (PMID 26776957)

When should I take rhodiola?

In the morning. Rhodiola is activating, and taking it late in the day can interfere with sleep. Trials typically used 400 to 600 mg of standardized extract daily.

Can I take rhodiola with other supplements?

Often yes, but check for overlap and tell your doctor. Rhodiola may interact with antidepressants, stimulants, and blood pressure medication. Source: MSKCC rhodiola monograph. Some women pair morning rhodiola with a broader formula like The Shift, with their clinician informed.

Does rhodiola affect hormones?

Not in any way proven in humans. Laboratory work suggests some rhodiola compounds may interact with estrogen receptors, which is why researchers proposed studying it as a natural SERM. No trial has confirmed a hormonal effect in women, so read hormone claims on rhodiola labels with skepticism.

Read next

• Adaptogens for perimenopause: what they do and don't do
• Why perimenopause drains your energy
• Ashwagandha for menopause: what the evidence shows
• Cortisol and perimenopause
• Chinese herbs for menopause